Company / Debt per Share
Lilly (Eli) Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$45.24
FY2025
5-year range
$16.24 / $45.24
FY2021-FY2025
Trend
+38.9%
vs FY2024
Sector context
#5 of 82
Health Care
What the data says
Among 82 Health Care companies, Lilly (Eli) is in the bottom 6% for debt per share. Debt per Share has increased for 3 consecutive years, from $16.24 in FY2022 to $45.24 in FY2025.
Based on SEC 10-K filings.
45.24 in FY2025 with a 5-year CAGR of +23.4%. Top quartile in the Health Care sector.
Increased from $20.96 to $45.24 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- +40.7%
- 5-Year CAGR
- +23.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 82This company $45.24 Sector average $126.59
▼
-64.3% below sector average
Key checks
Key Insights
- Lilly (Eli)'s debt per share has grown for 3 consecutive years.
- In FY2025, debt per share increased 38.9% year-over-year.
- Ranks #5 out of 82 companies in the Health Care sector.
- Lowest debt per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $45.24 | +38.9% |
| FY2024 | $32.58 | +55.5% |
| FY2023 | $20.96 | +29.1% |
| FY2022 | $16.24 | -9.3% |
| FY2021 | $17.89 | +13.1% |
| FY2020 | $15.82 | +22.0% |
| FY2019 | $12.96 | +49.7% |
| FY2018 | $8.66 | -7.1% |
| FY2017 | $9.33 | +11.3% |
| FY2016 | $8.38 | +14.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026